The technologies made available through resources provided by UF and private philanthropy allow our investigators to continue conducting state-of-the-art clinical research trials, moving us closer to a cure for diabetes.

Over the past 40 years, UF research has been fundamental to understanding the genetic, immune, and metabolic markers associated with type 1 diabetes. Our collaborative approach to understanding type 1 diabetes is backed by

the emphasis that the disease begins long before symptomatic onset. We’re working on all aspects of the disease, from identifying at-risk individuals to reducing complications following onset.

At the UF Diabetes Institute, we are working to unlock the mysteries of type 2 diabetes and its complications, identify risk factors, and innovate new ways to treat, educate, and ultimately prevent the disease.